Acutus Medical Inc (AFIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,547 | -81,663 | -39,616 | -117,683 | -101,981 |
| Depreciation Amortization | 1,930 | 17 | 14,060 | 9,571 | 5,155 |
| Accounts receivable | -4,048 | -1,074 | -464 | -1,473 | -1,897 |
| Accounts payable and accrued liabilities | -1,485 | 288 | -204 | -871 | 2,283 |
| Other Working Capital | -4,009 | 916 | -2,614 | -3,788 | -6,098 |
| Other Operating Activity | -14,501 | 18,398 | -60,079 | 14,562 | 17,369 |
| Operating Cash Flow | $-31,660 | $-63,118 | $-88,917 | $-99,682 | $-85,169 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -112 | -219 | -228 | -9,973 | -11,225 |
| Net Acquisitions | 18,672 | 17,000 | 70,000 | N/A | N/A |
| Purchase Of Investment | 0 | -39,765 | -54,508 | -87,258 | -114,694 |
| Sale Of Investment | 3,250 | 82,750 | 93,241 | 116,297 | 62,095 |
| Other Investing Activity | 339 | -1,211 | -3,754 | 0 | 0 |
| Investing Cash Flow | $22,149 | $58,555 | $104,751 | $19,066 | $-63,824 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 34,825 | 0 | N/A |
| Debt Repayment | -2,625 | 0 | -44,550 | 0 | N/A |
| Common Stock Issued | 0 | 29 | 281 | 83,808 | 166,933 |
| Common Stock Repurchased | N/A | N/A | -111 | 0 | N/A |
| Other Financing Activity | -266 | -2,693 | -2,061 | -4,239 | -2,500 |
| Financing Cash Flow | $-2,891 | $-2,664 | $-11,616 | $79,569 | $164,433 |
| Exchange Rate Effect | 221 | 2,079 | 2,909 | -116 | 342 |
| Beginning Cash Position | 26,200 | 31,348 | 24,221 | 25,384 | 9,602 |
| End Cash Position | 14,019 | 26,200 | 31,348 | 24,221 | 25,384 |
| Net Cash Flow | $-12,181 | $-5,148 | $7,127 | $-1,163 | $15,782 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,660 | -63,118 | -88,917 | -99,682 | -85,169 |
| Capital Expenditure | -112 | -219 | -228 | -9,973 | -11,225 |
| Free Cash Flow | -31,772 | -63,337 | -89,145 | -109,655 | -96,394 |